Quantifying antigenic relationships among the lyssaviruses.
All lyssaviruses cause fatal encephalitis in mammals. There is sufficient antigenic variation within the genus to cause variable vaccine efficacy, but this variation is difficult to characterize quantitatively: sequence analysis cannot yet provide detailed antigenic information, and antigenic neutralization data have been refractory to high-resolution robust interpretation. Here, we address these issues by using state-of-the-art antigenic analyses to generate a high-resolution antigenic map of a global panel of 25 lyssaviruses. We compared the calculated antigenic distances with viral glycoprotein ectodomain sequence data. Although 67% of antigenic variation was predictable from the glycoprotein amino acid sequence, there are in some cases substantial differences between genetic and antigenic distances, thus highlighting the risk of inferring antigenic relationships solely from sequence data at this time. These differences included epidemiologically important antigenic differences between vaccine strains and wild-type rabies viruses. Further, we quantitatively assessed the antigenic relationships measured by using rabbit, mouse, and human sera, validating the use of nonhuman experimental animals as a model for determining antigenic variation in humans. The use of passive immune globulin is a crucial component of rabies postexposure prophylaxis, and here we also show that it is possible to predict the reactivity of immune globulin against divergent lyssaviruses.
Horton
D L
DL
Rabies and Wildlife Zoonoses, Veterinary Laboratories Agency Weybridge, New Haw, Addlestone, Surrey KT15 3NB, UK. d.horton@vla.defra.gsi.gov.uk
McElhinney
L M
LM
Marston
D A
DA
Wood
J L N
JL
Russell
C A
CA
Lewis
N
N
Kuzmin
I V
IV
Fouchier
R A M
RA
Osterhaus
A D M E
AD
Fooks
A R
AR
Smith
D J
DJ
D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D000940:Antigenic Variation; D000956:Antigens, Viral / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D002460:Cell Line; D006224:Cricetinae; D006801:Humans; D018114:Lyssavirus / Q000737:chemistry / Q000145:classification / Q000235:genetics / Q000276:immunology*; D051379:Mice; D008969:Molecular Sequence Data; D009500:Neutralization Tests; D011817:Rabbits; D018353:Rhabdoviridae Infections / Q000276:immunology / Q000821:virology*; D017386:Sequence Homology, Amino Acid; D014764:Viral Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology*
D000914:Antibodies, Viral; D000956:Antigens, Viral; D014764:Viral Proteins
Emerg Infect Dis. 2008 Jun;14(6):926-8
18507903
Muscle Nerve. 2000 May;23(5):720-30
10797395
J Virol. 2005 Aug;79(16):10487-97
16051841
J Gen Virol. 2001 Dec;82(Pt 12):2861-2867
11714960
Virus Res. 2008 Jul;135(1):10-21
18359532
Vaccine. 1988 Dec;6(6):533-9
3245296
Vaccine. 1999 Oct 14;18(5-6):479-86
10519937
J Virol. 1991 Aug;65(8):4198-203
1712859
Virus Res. 2005 Jul;111(1):28-43
15896400
J Gen Virol. 2007 Apr;88(Pt 4):1302-1314
17374776
J Virol. 2001 Apr;75(7):3268-76
11238853
Vaccine. 1988 Aug;6(4):362-8
2461007
J Virol. 1995 Aug;69(8):4957-62
7609065
Emerg Infect Dis. 2006 Dec;12(12):1965-7
17326954
J Immunol Methods. 1998 Mar 1;212(1):79-87
9671155
J Med Virol. 2003 Oct;71(2):281-9
12938204
Emerg Infect Dis. 2006 Aug;12(8):1274-7
16965714
Science. 2008 Apr 18;320(5874):340-6
18420927
Vaccine. 1998 Feb;16(4):417-25
9607065
PLoS Negl Trop Dis. 2009 Nov 03;3(11):e542
19888334
J Virol. 1988 Jan;62(1):1-7
2446011
J Infect Dis. 2006 Mar 15;193(6):796-801
16479514
Virology. 2002 Jan 20;292(2):247-57
11878928
Proteins. 1987;2(4):298-307
3448605
J Infect Dis. 2003 Jul 1;188(1):53-6
12825170
Dev Biol (Basel). 2006;125:195-204
16878477
Vaccine. 2005 Jul 14;23(32):4101-9
15964478
Science. 2004 Jul 16;305(5682):371-6
15218094
Virus Res. 2005 Jul;111(1):44-54
15896401
Clin Microbiol Rev. 2006 Jul;19(3):531-45
16847084
Rev Sci Tech. 2007 Apr;26(1):69-90
17633294
Science. 2009 Jul 10;325(5937):197-201
19465683
J Gen Virol. 1999 Aug;80 ( Pt 8):2041-2050
10466802
Trends Microbiol. 1993 Nov;1(8):317-20
8162418
J Virol. 1985 Mar;53(3):926-34
2579247
Vector Borne Zoonotic Dis. 2010 Mar;10(2):165-75
19492942
J Gen Virol. 1999 Oct;80 ( Pt 10):2545-2557
10573146
Emerg Infect Dis. 2003 Mar;9(3):333-7
12643828
Expert Rev Vaccines. 2005 Aug;4(4):533-40
16117710
Bull World Health Organ. 2005 May;83(5):360-8
15976877
Comp Immunol Microbiol Infect Dis. 1982;5(1-3):101-7
6181927
Rev Sci Tech. 1992 Sep;11(3):735-60
1472723
J Virol. 2007 Apr;81(8):4315-22
17287258
Zentralbl Bakteriol Mikrobiol Hyg A. 1985 Apr;259(2):268-74
2409716
Science. 2009 Oct 30;326(5953):726-8
19900931
J Clin Microbiol. 2009 Nov;47(11):3653-62
19776232
Dev Biol (Basel). 2006;125:185-93
16878476
Rev Infect Dis. 1988 Nov-Dec;10 Suppl 4:S785-98
3206089
J Clin Microbiol. 2008 Apr;46(4):1451-61
18305130
Virus Res. 2003 Nov;97(2):65-79
14602198
J Virol. 2001 Sep;75(17):8096-104
11483755